BD 324702 - Ultra-Fine Insulin Syringe 0.3 cc 29 Gauge x 1/2 Inch U-100 Permanently Attached Needle

BD 324702 - Ultra-Fine Insulin Syringe 0.3 cc 29 Gauge x 1/2 Inch U-100 Permanently Attached Needle

The BD 324702 BD Ultra-Fine Insulin Syringe is a precision-engineered insulin delivery device designed to support accurate, comfortable subcutaneous injections for diabetes management. Manufactured by Becton, Dickinson and Company, this syringe features a permanently attached 29-gauge, 1/2-inch needle and a 0.3 cc barrel calibrated specifically for U-100 insulin.

The ultra-fine needle diameter and regular bevel design are intended to promote smooth insertion and consistent insulin delivery while helping minimize injection discomfort. Supplied sterile in individual blister packs, this syringe supports safe, hygienic use in both clinical and home care environments.

Key Benefits

The 29-gauge ultra-fine needle is designed to enhance patient comfort by reducing penetration force and tissue trauma during injection. The permanently attached needle eliminates dead space, supporting more accurate insulin dosing and reducing medication waste.

Clear, conventional graduations on the 0.3 cc barrel allow precise measurement of small insulin doses, which is especially beneficial for patients requiring fine dose adjustments. Single-use, sterile packaging supports infection prevention and consistent performance.

Compatibility and Applications

This insulin syringe is specifically calibrated for U-100 insulin and is intended for subcutaneous insulin administration only. The permanently attached needle ensures secure, ready-to-use functionality without additional assembly.

Typical applications include daily insulin injections for patients with diabetes in hospitals, outpatient clinics, long-term care facilities, and home care settings under clinician guidance.

Usage Guidelines

The syringe should be removed from its sterile blister pack immediately prior to use and handled using aseptic technique. The prescribed insulin dose should be drawn carefully, ensuring accurate alignment with the barrel graduations.

After injection, the entire syringe should be disposed of in an approved sharps container. The product is intended for single use only and should not be reused or shared.

Certifications, Safety Standards, and Regulatory Approvals

The BD Ultra-Fine Insulin Syringe is manufactured under quality management systems aligned with FDA medical device regulations and internationally recognized manufacturing standards. These controls help ensure sterility, dosing accuracy, and consistent needle performance.

Regulatory compliance supports the products use in regulated healthcare environments and patient self-administration settings across the United States.

Comparison with Competitor Products

Compared with syringes using larger gauge needles or detachable needle designs, the BD Ultra-Fine syringe offers enhanced comfort and dosing precision through its ultra-fine, permanently attached needle. While some competitor products may offer similar capacities, BD syringes are widely trusted for consistent graduations, reliable needle sharpness, and reduced dead space.

Healthcare providers often recommend BD Ultra-Fine insulin syringes for patients who prioritize comfort, accuracy, and ease of use.

Typical User Profile and Application Scenarios

Typical users include patients with diabetes, caregivers, nurses, and clinicians responsible for insulin administration and diabetes education.

The syringe is particularly effective for patients requiring small, precise insulin doses and for those performing frequent daily injections in home or clinical settings.

Best Practices for Use and Maintenance

Best practice includes verifying the correct insulin concentration, using proper injection technique, and rotating injection sites as recommended by healthcare providers. The syringe should remain sealed until use to maintain sterility.

As a disposable medical device, no maintenance or reprocessing is required. Prompt disposal after use supports sharps safety and infection control compliance.

Regulatory and Safety Information

The BD 324702 BD Ultra-Fine Insulin Syringe is classified as a regulated medical device and complies with applicable FDA requirements. Its design supports adherence to diabetes care standards and institutional safety protocols.

Patients and caregivers should follow clinician instructions and local regulations regarding sharps disposal to ensure safe use.

How to Order

The BD 324702 BD Ultra-Fine Insulin Syringe 0.3 cc 29 Gauge x 1/2 Inch U-100 is available for purchase through the CIA Medical website. Add the product to your cart and proceed through the secure checkout process.

For bulk purchasing, long-term care supply needs, or additional assistance, contact CIA Medical customer service at 312 275 5850 or use the contact form available on this page for prompt support.